Chugai Pharmaceutical Co., Ltd. Share Price
Stocks
4519
JP3519400000
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
07:30:00 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 7,101.00 JPY | +3.14% |
|
-1.16% | -13.85% |
| 08-18 | Chugai grants GSK exclusive global license for AID351 dengue antibody | AN |
| 08-14 | Japanese shares climb on bets Fed to hold rates steady; Topix poised for record close | RE |
| Market Cap | 11,683B 73.42B 62.88B 58.79B 53.91B 101B 7,028B 103B 691B 271B 3,518B 276B 270B | P/E 2026 * |
23x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10,773B 67.7B 57.98B 54.21B 49.71B 93.28B 6,480B 95.28B 637B 250B 3,244B 254B 249B | EV / Sales 2026 * |
7.76x | EV / Sales 2027 * | 6.87x |
| Free-Float |
38.12% | Yield 2026 * |
1.92% | Yield 2027 * | 2.19% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +3.14% | ||
| 1 week | -1.16% | ||
| Current month | +2.44% | ||
| 1 month | -3.06% | ||
| 3 months | -10.52% | ||
| 6 months | -25.99% | ||
| Current year | -13.85% |
| 1 week | 6,831 |  | 7,141 |
| 1 month | 6,575 | | 7,509 |
| Current year | 6,575 | | 10,700 |
| 1 year | 6,002 | | 10,700 |
| 3 years | 4,197 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 28/02/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 27/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 29/02/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 27/03/2024 |
| Director/Board Member | 51 | 28/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.14% | -1.16% | +8.59% | +68.47% | 71.47B | |
| -2.81% | +1.98% | +76.96% | +127.73% | 1,141B | |
| -2.21% | +2.50% | +50.38% | +55.01% | 659B | |
| -1.56% | +5.25% | +26.98% | +74.39% | 470B | |
| +1.20% | +1.72% | +42.89% | +45.78% | 366B | |
| -0.61% | +1.72% | +25.21% | +41.34% | 302B | |
| +0.32% | +3.30% | +2.60% | +13.42% | 254B | |
| -1.95% | +4.22% | +46.75% | +65.66% | 239B | |
| -1.10% | -1.12% | -14.91% | -52.66% | 207B | |
| -2.82% | +5.57% | +21.58% | +89.04% | 183B | |
| Average | -0.84% | +3.28% | +28.70% | +52.82% | 389.24B | |
| Weighted average by Cap. | -1.55% | +4.15% | +43.76% | +70.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,389B 8.73B 7.47B 6.99B 6.41B 12.02B 835B 12.28B 82.12B 32.22B 418B 32.79B 32.08B | 1,533B 9.63B 8.25B 7.71B 7.07B 13.28B 922B 13.56B 90.67B 35.57B 462B 36.21B 35.42B |
| Net income | 507B 3.19B 2.73B 2.55B 2.34B 4.39B 305B 4.48B 29.99B 11.77B 153B 11.98B 11.72B | 588B 3.69B 3.16B 2.96B 2.71B 5.09B 354B 5.2B 34.77B 13.64B 177B 13.88B 13.58B |
| Net Debt | -910B -5.72B -4.9B -4.58B -4.2B -7.88B -548B -8.05B -53.83B -21.12B -274B -21.49B -21.03B | -1,152B -7.24B -6.2B -5.8B -5.31B -9.97B -693B -10.19B -68.12B -26.72B -347B -27.2B -26.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | JP¥7,101.00 | +3.14% | 2,536,300 |
| 19/08/26 | JP¥6,885.00 | +0.55% | 3,127,400 |
| 18/08/26 | JP¥6,847.00 | -0.25% | 2,180,500 |
| 17/08/26 | JP¥6,864.00 | -1.00% | 1,900,800 |
| 14/08/26 | JP¥6,933.00 | -3.37% | 4,618,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
